行情

OSUR

OSUR

奥瑞许科技
NASDAQ

实时行情|Nasdaq Last Sale

13.19
+0.39
+3.05%
交易中 14:38 09/21 EDT
开盘
13.02
昨收
12.80
最高
13.57
最低
12.93
成交量
70.22万
成交额
--
52周最高
17.79
52周最低
8.58
市值
9.50亿
市盈率(TTM)
180.44
分时
5日
1月
3月
1年
5年
OraSure 获得 2.05 亿美元的 OTC COVID-19 测试合同
The Defense Logistics Agency has awarded OraSure Technologies Inc (NASDAQ: OSUR) a procurement contract for its InteliSwab COVID-19 Rapid Test for over-the-counter use.
Benzinga · 1天前
简报-OraSure 获得价值 2.05 亿美元的 Inteliswab™ 合同,以供应 OTC COVID-19 测试套件
reuters.com · 1天前
OraSure 从国防后勤局获得价值 2.05 亿美元的 InteliSwab 采购合同,作为国家大流行应对措施的一部分,提供非处方试剂盒
OraSure Technologies, Inc. (NASDAQ:OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that the Defense Logistics Agency has awarded the Company a
Benzinga · 1天前
OraSure 从国防后勤局收到价值 2.05 亿美元的 InteliSwab™ 采购合同,以提供非处方 (OTC) 套件作为国家大流行应对措施的一部分
BETHLEHEM, Pa., Sept. 20, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that the Defense Logistics Agency has awarded the...
GlobeNewswire · 1天前
从周五开始的 48 个最大的推动者
Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by AstraZeneca for patients with unresectable, stage 3 non-small cell lung cancer.
Benzinga · 1天前
OraSure Technologies 从美国国防后勤局获得 2.05 亿美元的合同,以提供 COVID-19 测试
MT Newswires · 1天前
Orasure 获得约 5.129 亿美元的抗原检测试剂盒合同
Orasure (NASDAQ:OSUR) has been awarded a maximum ~$512.94M ID/IQ contract for over-the-counter antigen test kits. This is a one-year contract with no option periods. Location of performance is all 50
Seekingalpha · 3天前
OraSure Technologies, Inc.(纳斯达克股票代码:OSUR)的财务状况太模糊,无法与当前的股价动能联系起来:股票有什么?
OraSure Technologies' (NASDAQ:OSUR) stock is up by a considerable 12% over the past three months. However, we wonder if...
Simply Wall St. · 09/10 15:14
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解OSUR最新的财务预测,通过OSUR每股收益,每股净资产,每股现金流等数据分析奥瑞许科技近期的经营情况,然后做出明智的投资选择。
分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测OSUR价格均价为14.08,最高价位20.00,最低价为11.00。
EPS
机构持股
总机构数: 292
机构持股: 7,209.47万
持股比例: 100.12%
总股本: 7,200.89万
类型机构数股数
增持
56
507.80万
建仓
27
50.30万
减持
67
383.54万
平仓
31
138.10万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设备、用品及经销
+0.27%
医疗设备和用品
+0.50%
高管信息
Non-Executive Chairman/Independent Director
Michael Celano
President/Chief Executive Officer/Director
Stephen Tang
Chief Financial Officer/Senior Vice President/Director of Investor Relations
Scott Gleason
Executive Vice President
Lisa Nibauer
Executive Vice President
Kathleen Weber
Senior Vice President/Chief Compliance Officer/General Counsel/Secretary
Jack Jerrett
Vice President - Finance/Controller
Michele Miller
Independent Director
Mara Aspinall
Independent Director
James Datin
Independent Director
Eamonn Hobbs
Independent Director
Ronny Lancaster
Independent Director
Lelio Marmora
Independent Director
David Shulkin
暂无数据
OSUR 简况
OraSure Technologies, Inc.(OraSure)从事开发、制造、营销并销售口腔液诊断产品以及运用其技术和其他诊断产品的标本采集设备,包括免疫测定和用于其他标本类型的其他体外诊断测试。该公司分为两个部门:OSUR部门和DNAG部门。OSUR部门从事诊断产品、标本采集设备和医疗设备的开发、制造和销售业务。DNAG(分子收集系统业务)主要包括开发、制造和销售口腔液收集装置,以收集、稳定和储存遗传物质样品,用于进行分子测试。

微牛提供OraSure Technologies, Inc.(NASDAQ-OSUR)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的OSUR股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易OSUR股票基本功能。